FindTrial
Sign In

Longitudinal changes in cognitive function in patients with chemotherapy for lung cancer and their predictors Analytical research

Longitudinal changes in cognitive function in patients with chemotherapy for lung cancer and their predictors Analytical research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076232
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-09-30
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

patient cases:None

Sponsors

National Natural Science Foundation of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with primary lung cancer by pathology; ? Inpatients who plan to receive 4-6 cycles of chemotherapy for the first time; ?KPS score > 60 points; ? Age =18 years old; ? Know your condition and cancer diagnosis; ? Have certain understanding and language expression skills and agree to participate in the study.

Exclusion criteria

Exclusion criteria: ?Have a past or current mental illness or mental disorder; ? Patients with other malignant tumors or other serious life-threatening diseases; ? Participants in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy-Cognitive Function, FACT-Cog (Version-3);Hospital Anxiety and Depression Scale, HADS;Cancer Fatigue Scale, CFS;The Pittsburgh Sleep Quality Index,PSQI;—

Countries

China

Contacts

Public ContactJingfang Hong

Anhui Medical University

hongjingfang@ahmu.edu.cn+86 159 5517 9337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026